🔎 Trials Near Me

መነሻ › በርኪት ሊምፎማ › ዲስትሪክት ኦፍ ኮሎምቢያ › Washington

በWashington፣ DC ለበርኪት ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለበርኪት ሊምፎማ የሚደረጉ 9 ጥናቶች በWashington እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • MedStar Georgetown University Hospital, Washington D.C.
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦክቶ 2026 · NCT03739814

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • MedStar Georgetown University Hospital, Washington D.C.
  • Children's National Medical Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 ማይል ርቀት
366 Days – 46 Years · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦክቶ 2026 · NCT06124157

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
እድሜ ከ3 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT05442515

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT03223610

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Children's National Medical Center, Washington D.C.
365 Days · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07648264

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Children's National Medical Center, Washington D.C.
እድሜ ከ1 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT04546399

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT05389423

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Children's National Medical Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 ማይል ርቀት
365 Days – 25 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT03959085

በሌሎች ከተሞች ለበርኪት ሊምፎማ የሚደረጉ ጥናቶች

በWashington ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ7 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።